聯泓新科(003022.SZ):擬以1.5億元增資生物可降解材料公司
格隆匯6月1日丨聯泓新科(003022.SZ)公佈,江西科院生物新材料有限公司(“標的公司”)主要從事生物可降解材料PLA的研發、生產與銷售,是國內成功自主開發出“高光純乳酸—高光純丙交酯—聚乳酸”全產業鏈技術的企業之一。
公司持續重點關注生物可降解材料相關產業,基於公司發展戰略,為佈局生物可降解材料領域,公司與聯泓集團有限公司(“聯泓集團”)、江西省科院生物技術有限責任公司(“生物技術公司”)及上海玟琪商務諮詢有限公司(“上海玟琪”)於2021年6月1日在江西省九江市簽訂《關於江西科院生物新材料有限公司增資的協議書》。公司擬對標的公司進行增資,增資金額為人民幣1.5億元,增資後持有標的公司42.86%的股權。如此次增資完成,標的公司將成為公司的聯營企業。
聯泓新科對標的公司增資款的用途為補充標的公司的資本金及運營流動資金,用於現有千噸級示範線改造及在江西省九江市濂溪區化纖工業基地建設一期3萬噸/年PLA全產業鏈項目,包括乳酸發酵提純、丙交酯合成提純、聚乳酸合成以及聚乳酸解聚化學循環等。
生物可降解材料是解決傳統塑料污染的主要途徑,聚乳酸(PLA)是重要的生物可降解材料品種,是目前已產業化的生物可降解材料之一,產品市場需求旺盛,持續供不應求,未來市場空間廣闊。PLA產業化技術長期被國外壟斷,目前僅少數企業掌握。
聯泓新科此次對標的公司增資,將實現公司在生物可降解材料領域的戰略布局。標的公司規劃在2025年前分兩期建設“13萬噸/年生物可降解材料聚乳酸全產業鏈項目”(一期3萬噸/年,二期10萬噸/年)。如標的公司順利推進PLA全產業鏈項目建設,將為公司後續發展培育新的經濟增長點,助力將公司打造成為新材料平台型企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.